Search

Scholarly Works (1 results)

Article
Peer Reviewed

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial

Bastian, Boris;
Behr, Spencer;
McCalmont, Timothy;
Algazi, AP;
Cha, E;
Ortiz-Urda, SM;
McCalmont, TH;
Bastian, BC;
Hwang, J;
Pampaloni, MH;
Chong, K;
Cortez, B

UC San Francisco Previously Published Works (2015)

© Cancer Research UK Background:Simultaneous chemotherapy with vascular endothelial growth factor (VEGF) inhibition has not shown additional benefit over chemotherapy alone in advanced melanoma. We tested administration of the potent VEGF inhibitor axitini